Jump to content

GBR-13119

From Wikipedia, the free encyclopedia
GBR-13119
Names
Preferred IUPAC name
1-[2-(Diphenylmethoxy)ethyl]-4-[3-(4-fluorophenyl)propyl]piperazine
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
  • InChI=1S/C28H33FN2O/c29-27-15-13-24(14-16-27)8-7-17-30-18-20-31(21-19-30)22-23-32-28(25-9-3-1-4-10-25)26-11-5-2-6-12-26/h1-6,9-16,28H,7-8,17-23H2
    Key: IYWFOWPCJVOCMB-UHFFFAOYSA-N
  • InChI=1/C28H33FN2O/c29-27-15-13-24(14-16-27)8-7-17-30-18-20-31(21-19-30)22-23-32-28(25-9-3-1-4-10-25)26-11-5-2-6-12-26/h1-6,9-16,28H,7-8,17-23H2
    Key: IYWFOWPCJVOCMB-UHFFFAOYAU
  • C1CN(CCN1CCCC2=CC=C(C=C2)F)CCOC(C3=CC=CC=C3)C4=CC=CC=C4
Properties
C28H33FN2O
Molar mass 432.583 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

GBR-13119 is a psychostimulant and dopamine re-uptake inhibitor.[1]

References

[edit]
  1. ^ Kilbourn, Michael R.; Phil S. Sherman; Teresa Pisani (1992). "Repeated reserpine administration reduces in vivo [18F]GBR 13119 binding to the dopamine uptake site" (PDF). European Journal of Pharmacology. 216 (1): 109–112. doi:10.1016/0014-2999(92)90216-Q. hdl:2027.42/30038. ISSN 0014-2999. PMID 1526249.